[go: up one dir, main page]

EP1427425A4 - Procede de traitement de l'obesite et de la paralysie musculaire par des aides ergogeniques - Google Patents

Procede de traitement de l'obesite et de la paralysie musculaire par des aides ergogeniques

Info

Publication number
EP1427425A4
EP1427425A4 EP01948319A EP01948319A EP1427425A4 EP 1427425 A4 EP1427425 A4 EP 1427425A4 EP 01948319 A EP01948319 A EP 01948319A EP 01948319 A EP01948319 A EP 01948319A EP 1427425 A4 EP1427425 A4 EP 1427425A4
Authority
EP
European Patent Office
Prior art keywords
musculator
ergonic
obesitas
flushing
tools
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01948319A
Other languages
German (de)
English (en)
Other versions
EP1427425A1 (fr
Inventor
William Winder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham Young University
Original Assignee
Brigham Young University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham Young University filed Critical Brigham Young University
Publication of EP1427425A1 publication Critical patent/EP1427425A1/fr
Publication of EP1427425A4 publication Critical patent/EP1427425A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP01948319A 2000-06-09 2001-06-11 Procede de traitement de l'obesite et de la paralysie musculaire par des aides ergogeniques Withdrawn EP1427425A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21070800P 2000-06-09 2000-06-09
US210708P 2000-06-09
PCT/US2001/018812 WO2001093874A1 (fr) 2000-06-09 2001-06-11 Procede de traitement de l'obesite et de la paralysie musculaire par des aides ergogeniques

Publications (2)

Publication Number Publication Date
EP1427425A1 EP1427425A1 (fr) 2004-06-16
EP1427425A4 true EP1427425A4 (fr) 2006-04-05

Family

ID=22783952

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01948319A Withdrawn EP1427425A4 (fr) 2000-06-09 2001-06-11 Procede de traitement de l'obesite et de la paralysie musculaire par des aides ergogeniques

Country Status (3)

Country Link
EP (1) EP1427425A4 (fr)
AU (1) AU2001269785A1 (fr)
WO (1) WO2001093874A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192495B1 (es) 2002-03-21 2005-02-16 Universidad De Barcelona Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina).
EP1633883B1 (fr) * 2003-06-17 2008-09-10 Medical Research Council Procede de dosage de l'activite de phosphorylation lkb1
WO2007082309A2 (fr) * 2006-01-16 2007-07-19 The Board Of Regents Of The University Of Texas System Procédés et composition induisant une torpeur chez un sujet
WO2008083330A2 (fr) 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Procédés permettant une amélioration des performances d'exercice
EP2234622A4 (fr) * 2007-12-28 2011-03-09 Salk Inst For Biological Studi Méthodes améliorant les performances et le tonus musculaires
US20140065099A1 (en) 2011-02-15 2014-03-06 Ecole Polytechnique Federale De Lausanne (Epfl) Methods of Treating Mitochondrial Dysfunction
US8895520B2 (en) 2011-10-26 2014-11-25 Universite Nice Sophia Antipolis Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide
CN107249349B (zh) * 2014-12-10 2021-06-08 马斯公司 用于调节味觉受体的方法
CN112739352B (zh) * 2018-08-06 2024-01-23 斯凯拉克生物科技有限责任公司 活化amp-活化的蛋白激酶的化合物及其用途
US11779590B2 (en) 2020-10-30 2023-10-10 Skylark Bioscience Llc AMP-activated protein kinase activating compounds and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
WO2001093873A1 (fr) * 2000-06-06 2001-12-13 Trustees Of Boston University Utilisation de aicar et de composes associes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658889A (en) * 1989-01-24 1997-08-19 Gensia Pharmaceuticals, Inc. Method and compounds for aica riboside delivery and for lowering blood glucose
AU7629200A (en) * 1999-08-09 2001-03-05 Trustees Of Boston University Method of maintaining vascular integrity using aicar (5-amino-4-imidazole riboside) and related compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5777100A (en) * 1990-08-10 1998-07-07 Gensia Inc. AICA riboside analogs
WO2001093873A1 (fr) * 2000-06-06 2001-12-13 Trustees Of Boston University Utilisation de aicar et de composes associes

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HOLMES, B.F. ET AL.: "Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle", AM J PHYSIOL, vol. 87, no. 5, November 1999 (1999-11-01), pages 1990 - 1995, XP002364671 *
See also references of WO0193874A1 *
VINCENT M FJ ET AL: "HYPOGLYCAEMIC EFFECT OF AICARIBOSIDE IN MICE", DIABETOLOGIA, BERLIN, DE, vol. 39, no. 10, 1996, pages 1148 - 1155, XP008008094, ISSN: 0012-186X *
WINDER,W.W AND HARDIE, D.G.: "AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes", AM J PHYSIOL ENDOCRINOL METAB, vol. 277, no. 1, July 1999 (1999-07-01), pages E1 - E10, XP002364672 *
WINDER,W.W. ET AL.: "Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle", J APPL PHYSIOL, vol. 88, 2000, pages 2219 - 2226, XP002364670 *

Also Published As

Publication number Publication date
EP1427425A1 (fr) 2004-06-16
AU2001269785A1 (en) 2001-12-17
WO2001093874A1 (fr) 2001-12-13

Similar Documents

Publication Publication Date Title
DE60227095D1 (de) Zusammensetzungen und verfahren zur behandlung von abgebundenem gips
EP1626730A4 (fr) Procede, dispositif et composition de traitement de l'acne
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
EP1469871A4 (fr) Methode de traitement de l'apoptose et compositions associees
DE60132767D1 (de) Verfahren und vorrichtung zur herstellung von überlappungssäumen
DE60231601D1 (de) Einrichtung und verfahren zur behandlung
EP1701664A4 (fr) Systeme et procede de traitement d'un tissu
DE50006193D1 (de) Verfahren zur herstellung von otoplastiken und otoplastik
DE69810584D1 (de) Verfahren und Methode zur Behandlung von Abfällen
EP1324780A4 (fr) Procedes de traitement de l'arrhythmie cardiaque
DE60120520D1 (de) Verfahren zur behandlung von abwasser
DE60143831D1 (de) Massgeschneidertes rohteil und verfahren zur herstellung des teiles
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60122839D1 (de) Verfahren zur Behandlung von chromatbelastetem Abwasser
EP1443820A4 (fr) Composition et procede de traitement de la reaction du greffon contre l'hote
DE60128788D1 (de) Zusammensetzung und verfahren zur bekämpfung von pflanzenschädlichen arthropoden
DE60114439D1 (de) Verfahren zur antimikrobiellen behandlung von fasermaterialien
DE60223688D1 (de) Verfahren zur behandlung von multiplem myelom
EP1635801A4 (fr) Methodes de traitement et de prevention de l'arythmie cardiaque
ATE279401T1 (de) Verbindungen und verfahren zur behandlung von asthma, allergie und entzündlichen erkrankungen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60036899D1 (de) Chemikalie und verfahren zur wasserbehandlung
DE60133996D1 (de) Kosmetisches VERFAHREN ZUR BEHANDLUNG VON Celluliten
DE69834578D1 (de) Verfahren zur behandlung von zementaufschlämmungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20030314

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 3/00 20060101ALI20060131BHEP

Ipc: A61P 21/00 20060101ALI20060131BHEP

Ipc: A61K 31/70 20060101AFI20011219BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20060220

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060921